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Thiol–disulfide oxidoreductase systems of bacterial cytoplasm and eukaryotic cytosol favor reducing conditions and protein thiol groups,
while bacterial periplasm and eukaryotic endoplasmatic reticulum provide oxidizing conditions and a machinery for disulfide bond formation in
the secretory pathway. Oxidoreductases of the thioredoxin fold superfamily catalyze steps in oxidative protein folding via protein–protein
interactions and covalent catalysis to act as chaperones and isomerases of disulfides to generate a native fold. The active site dithiol/disulfide of
thioredoxin fold proteins is CXXC where variations of the residues inside the disulfide ring are known to increase the redox potential like in
protein disulfide isomerases. In the catalytic mechanism thioredoxin fold proteins bind to target proteins through conserved backbone–backbone
hydrogen bonds and induce conformational changes of the target disulfide followed by nucleophilic attack by the N-terminally located low pKa
Cys residue. This generates a mixed disulfide covalent bond which subsequently is resolved by attack from the C-terminally located Cys residue.
This review will focus on two members of the thioredoxin superfamily of proteins known to be crucial for maintaining a reduced intracellular
redox state, thioredoxin and glutaredoxin, and their potential functions as facilitators and regulators of protein folding and chaperone activity.
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From bacteria to eukaryotic cells, cellular compartmentaliza-
tion provides well defined reaction chambers for the variety of
vital biochemical processes. One of the most distinguishing
features of the different compartments is their redox potential. In
general, the redox potential describes the tendency of a system to
either gain or lose electrons when new species are introduced.
Compartments with low redox potential will rather reduce newly
introduced compounds, while compartments with high redox
potential oxidize them. In this respect, protein cysteinyl side chains
are of particular interest, because their thiol group (P-SH) is sus-
ceptible to a number of oxidative modifications. The reversible
formation of inter- or intramolecular disulfides (P-S-S-P) is fre-
quently a prerequisite for the proper folding and function of a
protein or protein complex. Moreover, disulfide bond formation as
well as the reversible formation of protein glutathione (GSH)mixed⁎ Corresponding author. The Medical Nobel Institute for Biochemistry,
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act as regulatory switches modulating the activity of numerous
proteins in response to alterations in the cellular redox state. Severe
oxidative stress, i.e. the excessive formation of reactive oxygen
species, may lead to the formation of sulfenic (P-SOH), sulfinic (P-
SO2H) and sulfonic (P-SO3H) acid. The redox potential of the
bacterial cytoplasm as well as the eukaryotic cytosol normally
favors reduced thiol groups, while the bacterial periplasm and
the eukaryotic endoplasmatic reticulum provide the oxidizing
environments for disulfide bond formation in proteins to be
exported from the cell or to the cell surface. In biological systems,
thiol–disulfide exchange reactions are highly specific with respect
to the thiol groups involved. This specificity is the result of the
unique physico-chemical micro-environment of susceptible thiol
groups and of enzymatic catalysis by a group of oxidoreductases
that belong to the thioredoxin family of proteins.
2. The thioredoxin family of proteins
Thioredoxin (Trx), the eponymous founder of the thior-
edoxin family of proteins, was first identified as electron donor
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organisms, this group of enzymes is central for DNA synthesis
both during replication and repair [3]. The second member of
the Trx family, glutaredoxin (Grx), was discovered as a GSH-
dependent electron donor for RNR in an E. coli mutant lacking
Trx [4]. Today, the Trx protein family is first and foremost
defined by a structural motif named the Trx fold [5]. This fold is
common to a variety of functionally different proteins [6,7], for
instance, thiol–disulfide oxidoreductases, disulfide isomerases,
glutathione S-transferases [8], thiol dependent peroxidases [9],
and chloride intracellular channels [10].
2.1. The thioredoxin fold
The Trx fold motif consists of a central four-stranded β-sheet
surrounded by three α-helices [11,12]. This basic structure can
only be found in bacterial glutaredoxins, while thioredoxins
contain an additional β-sheet and α-helix at the N-terminus
[13]. Variations of this motif (Fig. 1) have also been identified in
the Trx fold domains of E. coli DsbA, a protein necessary for
disulfide bond formation [14], protein disulfide isomerases
(PDI) from human and yeast [15,16], and PDI homologous
proteins DsbC and DsbG from E. coli [17,18]. Noteworthy, the
Trx domain in these proteins is so well conserved that it can be
used to identify novel members of the family, as shown for
human PDIs [19].
Hallmarks of the Trx motif are a cis-proline residue located
before β-sheet three and the Cys-X-X-Cys active site motif
located on the loop connecting β-sheet one and α-helix oneFig. 1. Selected structures of thioredoxin (Trx) fold oxidoreductases from E. coli. T
additional elements are shown in magenta and blue. The cis-Pro residues are depicte
glutaredoxin 1 (1egr), monothiol glutaredoxin 4 (1yka), DsbA (1a2l), DsbC (1tjd),[11]. The question of why some of these structurally similar
proteins act as reductants while others are more efficient
oxidases was the subject of several investigations. These studies
revealed a major role of the two residues in between the two
active site cysteines. Even though other residues have been
described to affect the redox potential [20–22], the primary
focus of these studies has been on the amino acids in the active
sites. The nature and composition of these two amino acids
dramatically affects the standard redox potential of the particular
proteins. In E. coli, the strongest reductant, cytosolic Trx (Cys-
Gly-Pro-Cys), has a redox potential ofΔE′0=−270mV [23], the
strongest oxidant, periplasmatic DsbA (Cys-Pro-His-Cys), has a
redox potential of ΔE′0=−122 mV [24]. The redox potential of
human PDI (Cys-Gly-His-Cys) was determined to be ΔE′0=
−175 mV [25]. Mutation of the Cys-Gly-Pro-Cys active site in
Trx to the corresponding Cys-Gly-His-Cys active site of PDI
resulted in an increase of its standard midpoint potential to
ΔE′0=−235 mV and ΔE′0=−221 mV, respectively [23,26].
This change in redox potential was accompanied by a 10-fold
increase in PDI activity [23,27]. Exchange of Trx's active site
for the Cys-Pro-His-Cys motif found in DsbA proteins increased
the redox potential further to ΔE′0=−204 mV [26]. Corrobora-
tively, the redox potential of a DsbA mutant harboring the Cys-
Gly-Pro-Cys active site of Trx decreased by 92 mV [28].
2.2. The thioredoxin system
Trx utilizes the two cysteinyl residues in its Cys-Gly-Pro-Cys
active site to reduce the protein disulfide formed during thehe secondary structural elements of the Trx fold are shown in yellow and red,
d in purple, the active site Cys residues in grey. Trx1 (PDB entry: 1xob), dithiol
and DsbG (1v58).
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general disulfide reductase [29] reducing disulfide bonds by a
ping-pong mechanism [30]. Recently, it was shown by single
molecule force-clamp spectroscopy that efficient catalysis re-
quires a reorientation of the substrate disulfide bond [31]. This
investigation demonstrated, that the rate limiting step of Trx
activity is the orientation of the N-terminal active site cysteine
of Trx and the two disulfide bridged cysteines of the substrate
in a 180° angle (Fig. 2, 1). The resulting shortening of the overall
length of the substrate polypeptide by around 0.8 Å resulting in
a shortened projection of the disulfide bond is the condition
for the nucleophilic attack of the N-terminal Cys [31]. The N-Fig. 2. Interaction of thioredoxin (Trx) with proteins. Trx catalyzes reversibly
the reduction of disulfides via a covalent-mixed disulfide intermediate (see text).
The direction of the reaction depends on the redox potential of the environment.
Blue: human Trx1, red: substrate.terminal active site thiol of Trxs possesses an unusual low pKa
value [32]. Hence, the thiol group of this cysteinyl side chain
is readily deprotonated under physiological conditions. The
resulting thiolate acts as nucleophile attacking the target di-
sulfide bond to form a covalent intermediate mixed disulfide
between the Trx N-terminal active site and one of the substrate's
cysteinyl side chains [32] (Fig. 2, 2). This disulfide is sub-
sequently reduced by the C-terminal active site cysteinyl side
chain yielding the reduced substrate and a disulfide in the active
site of Trx (Fig. 2, 3). Subsequently, the disulfide in the active
site of Trx is reduced by the dimeric flavo-enzyme thioredo-
xin reductase (TrxR) at the expense of NADPH (for a more
detailed overview, see Refs. [12] and [33]) or by ferredoxin via
ferredoxin-dependent TR in chloroplasts [34].
Trxs (around 10–12 kDa) are ubiquitous proteins present in
all forms of life. E. coli, yeast and mammalian cells contain
two Trxs each [35]. The mammalian proteins are localized in the
cytosol/nucleus (Trx1) and in mitochondria (Trx2) [36]. Plants
contain a rich variety of Trxs with sometimes highly specialized
functions [34,37,38]. Trxs are crucial proteins for oxidative stress
defense, redox regulation of cellular function, and different
metabolic pathways (for detailed overviews: [5,39–42]). For
instance, Trxs are essential cofactors for DNA synthesis [1,43],
sulfur assimilation [44], and peroxiredoxins [45]. Trxs regulate the
activity of several transcription factors, such as NF-κB inmammals
[46], and metabolic enzymes such as fructose-1,6-bisphoshatase in
chloroplasts [47]. The importance of Trxs in several aspects of
human health, e.g. pregnancy, embryonic development, cardiovas-
cular and neurodegenerative diseases, or virus infection was ob-
ject of a recent review [42]. In the scope of this review, it is
important to note that a number of functions described for Trxs are
independent from their oxidoreductase activity, for instance E. coli
Trx as subunit of the T7 DNA polymerase complex [48], the redox
regulation of apoptosis signaling kinase 1 by human Trx [49], and
its activity as molecular (co-)chaperone (see below).
2.3. The glutaredoxin system
Glutaredoxins (Grxs) are small proteins, usually around 9–
15 kDa, existing in large number of isoforms in basically all
glutathione (GSH)-containing life forms. Based on their active
site motifs, Grxs can be divided in two major categories: the
dithiol Grxs (active site Cys-Pro-Tyr-Cys) and the monothiol
Grxs (active site: Cys-Gly-Phe-Ser).
Dithiol Grxs are general thiol–disulfide oxidoreductases
with high specificity for the GSH moiety. These Grxs are kept
reduced by GSH. The resulting glutathione disulfide (GSSG) is
reduced by glutathione reductase (GR) with electrons from
NADPH [50,51]. The classical dithiol Grxs efficiently reduce
some protein disulfides like that in E. coli ribonucleotide
reductase with a mechanism as described for Trxs above (dithiol
mechanism, Fig. 3A). However, the major action of Grxs seems
to be to reduce protein–GSH mixed disulfides (de-glutathiony-
lation) utilizing a mechanism that requires only the N-terminal
active site residue (monothiol mechanism, Fig. 3B, for a more
detailed overview, see reference [33]. E. coli contains three
dithiol glutaredoxins [52,53], yeast and mammalian cells
Fig. 3. Catalyzed reactions by oxidoreductases of the thioredoxin family of proteins. A) Reduction of intramolecular disulfides, B) reduction of protein–GSH mixed
disulfides, C) oxidation of thiol groups, formation of disulfides, and D) isomerization of disulfides.
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[54,55,56,57]. The situation in plants is far more complex, the
genome of Arabidopsis thaliana, for instance, encodes 14
dithiol Grxs [58].
Numerous functions have been described for Grxs, both as
electron donors as well as regulators of cellular function in
response to oxidative stress, for instance, in sulfur assimilation
[59,60], dehydroascorbate reduction [61] and the regulation of
cellular differentiation [62], transcription [63–65], and apopto-
sis [66–68]. Human glutaredoxins have been implied in several
diseases [42,33]. Recently, some dithiol glutaredoxins have
been described as iron–sulfur proteins. Human mitochondrial
Grx2 and poplarGrxC1were described as the first members of the
thioredoxin family of proteins coordinating an [2Fe2S] cluster
[69,70]. The clusters are coordinated by the N-terminal active site
cysteine of two Grx monomers and two non-covalently bound
molecules of GSH [69,71]. Both human Grx2 and poplar GrxC1
differ in their active site from the dithiol Grx consensus sequence
Cys-Pro-Tyr-Cys. Grx2 contains a serine, GrxC1 a glycine
instead of the active site proline residue. This exchange provides
enough flexibility and space for the non-covalent binding of GSH
and cluster coordination. In fact, when the active site of other Cys-
Pro-Tyr-Cys Grxs, for instance human Grx1 which normallycannot bind the cluster, are changed to Cys-Ser-Tyr-Cys or Cys-
Gly-Tyr-Cys, these proteins become able to complex an iron–
sulfur cluster [70,71]. In all other members of the thioredoxin
family containing a Cys-X-X-Cys active site the conserved cis-
proline was suggested to preclude metal binding [72].
The molecular mechanism and the functions of monothiol
glutaredoxins are only beginning to emerge (for a recent review
see [73]). Noteworthy, most monothiol Grxs are essentially
inactive in (dithiol) Grx-specific activity assays. Monothiol Grxs
fromE. coli, yeast, and vertebrates including humans are crucially
involved in iron–sulfur cluster biosynthesis and regulation of iron
homeostasis [74–79]. E. coli contains one monothiol Grx [80],
yeast five [81,82], and mammals two [78,83]. Similar to dithiol
Grxs, plants contain a rich variety of isoforms, e.g. at least 17
different monothiol Grxs are encoded in the genome of A.
thaliana [58].
3. Glutaredoxins and thioredoxins as facilitators of protein
folding
Trxs are by far the most well known members of the Trx
family. The investigations on these proteins, as well as Grxs,
provided general insights in functions and mechanisms of all
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general experiments were done in vitro, they provided important
concepts for the in vivo situation. Trxs and Grxs can be involved
in protein folding in many different ways (Fig. 4). The list of
proteins interacting with Trxs and Grxs is growing continuously.
The reduction of protein disulfides includes and often results
in, sometimes subtle, structural changes of the target protein
[31,12,84,85]. But Trxs and Grxs do not necessarily act as
disulfide reductases, under certain conditions these redoxins
promote disulfide bond formation and synergistically work
with PDI and/or chaperones.
3.1. Protein disulfide isomerization
PDIs catalyze the isomerization of disulfide bond formation
in the oxidative environments of the prokaryotic periplasm and
the eukaryotic endoplasmatic reticulum (Fig. 3D, overviews in
[86,87], and several contributions to this special issue of Bio-
chimica et Biophysica Acta). The investigation of an in vitro
model of the mechanism by which PDI catalyzes formation
of disulfide bonds in presence of GSSG indicated that PDI
primarily catalyzes formation and breakage of GSH–protein
mixed disulfides [88]. For this function, only the N-terminal
cysteine is essential as shown by kinetic analyses of ribonu-
clease A (RNase A) refolding [89]. As described above, Grxs
are GSH mixed disulfide reductases. Therefore the effect of
Grx in GSH-dependent refolding of reduced RNase A was
investigated. E. coli Grx1 displayed synergistic activity toge-
ther with PDI when the redox potential of the GSH redox buffer
was low enough to reduce the active site disulfide in Grx [90].
This synergistic effect can be explained by the fact that Grx (i)
converted formed mixed disulfides into intramolecular disulfide
bonds in the presence of PDI and (ii) was able to catalyze both
the formation and the reduction of GSH mixed disulfides [91].
For this last reason E. coli Grx1 was also able to refold RNase
A without PDI [91]. More recently, it was demonstrated that
oxidized E. coli Grx1 catalyzes refolding – in concert with
GSH – around 30 fold more efficient than PDI [92]. The further
investigation of the mechanism showed that Grx1 acted by the
monothiol mechanism (Fig. 3B). Only Cys11 was involved inFig. 4. Thioredoxin (Trx) and glutaredoxin (Grx) as facilitatothis activity indicating ribonuclease–GSH mixed disulfides as
substrate [90].
Therefore, GSH mixed disulfides were believed to be im-
portant folding intermediates in vivo. Moreover, the relative
amount of oxidized GSH in the ER is around 30 times higher
than in the cytoplasm [93] and the ratio of reduced and oxidi-
zed GSH is optimal for disulfide bond formation [94]. Today it
seems, that in eukaryotic systems GSH is needed as a redox
balancing system, providing reducing equivalents for the re-
duction of PDIs, and for the protection against reactive oxygen
species, which are formed during oxidation of PDIs via Ero1
using oxygen as the ultimate electron acceptor (reviewed in:
[95]).
Already back in 1986 it was shown that oxidized and a
mixture of oxidized and reduced Trx efficiently catalyzes the
refolding of reduced, denatured RNase, or oxidized, scrambled
RNase, respectively [96].
In E. coli, oxidative folding of proteins takes place in the
periplasm. The two PDIs DsbC and DsbG reduce incorrectly
formed disulfide bonds for further isomerization [86]. A con-
stant electron supply is guaranteed by the membrane protein
DsbD which itself is reduced by cytoplasmic Trx [97]. Thus,
electrons provided by Trx are essential for the correct oxidative
folding of proteins in the E. coli periplasm.
Moreover, Trx, when exported to the periplasm, is able to
complement E. coli strains deficient in the periplasmatic thiol
oxidase DsbA at concentrations that allow efficient re-oxidation
of Trx by DsbB [98]. As outlined before, Trxmutants mimicking
the active sites of other Trx fold oxidoreductases result in a
higher redox potential and increased PDI activity [23,99,26].
Corroboratively, these mutants were also more efficient in com-
plementation of DsbA deficiency in the periplasm [100,98].
Masip et al. [101] aimed at engineering a disulfide bond for-
mation pathway independent of DsbA andDsbB. To achieve this
goal, active site mutants of E. coli Trx1 were created by random
mutagenesis and tested for the ability to complement a DsbA/
DsbB deficient E. coli strain. Surprisingly, the most efficient
mutants contained the active sites Cys-Ala-Cys-Cys and Cys-
Ala-Cys-Ala and coordinated an [2Fe2S] cluster that was es-
sential for the catalysis of oxidative protein folding.rs and regulators of protein folding (for details see text).
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in the cytoplasm. Usually these proteins maintain a reducing
environment in the cytosol by reduction of disulfide bonds.
However, when the Trx system is impaired, for instance by
inhibition of TrxR, disulfide bond formation can occur in the
cytoplasm of E. coli [102]. This effect is enhanced if, in
addition to TrxR, GR and thereby the Grx system is disturbed
[103]. This formation of disulfide bridges in the cytoplasm of
E. coli is not only attributed to the lack of reductase activity of
Trxs and Grxs, but also to the accumulation of oxidized
redoxins that serve as oxidants and catalysts of disulfide bond
formation [104].
3.2. Chaperone activity and interactions
Besides their disulfide formation and isomerization activity,
thioredoxins and related oxidoreductases have been shown to
promote the folding of proteins independent of their redox
activity both by directly promoting protein folding and by
enhancing the refolding activity of other molecular chaperones.
As described above, the overall structure of the substrate is
shortened involving a conformational change of the polypeptide
during binding to Trx [31] (Fig. 2, 1). Hence, chaperone activity
is coupled to rate enhancements in the order of four to five orders
of magnitude compared to small reductants like dithiothreitol in
reduction of protein disulfides.
Thioredoxin fusion proteins have become a widely used tool
to avoid inclusion body formation during recombinant expres-
sion of proteins in E. coli. Several plasmids were constructed
for expression of these fusion proteins, for instance [105,106]. Trx
fusion markedly increased the levels of soluble proteins he-
terologously expressed in E. coli, for instance numerous mam-
malian proteins [105–107], Clostridium tetani fragment C of
tetanus toxin [108], or the single chain variable fragment of
antibodies [109]. The induction of correct folding was indepen-
dent of Trx's redox activity since fusion with a Trx mutant
harboring an Ala-Gly-Pro-Ala “active site”was as efficient as the
wild type Trx fusion partner [109]. Trx, covalently linked to the
protein of interest, may act as molecular chaperone preventing
precipitation and aggregation of the fused partners until these
reach a stable folding state [105,106]. Moreover, in cases where
Trx fusion failed to increase solubility of target proteins, it in-
creased the yield of soluble protein following solubilization
and refolding from inclusion bodies [110]. In vitro, Helicobacter
pylori Trx1, but not Trx2, promoted the renaturation of arginase
[111]. E. coli Trx1 and the Trx homologue YbbN/Trxsc were able
to refold citrate synthase and α-glucosidase with an efficiency
comparable to those of chaperones like DnaK and different heat
shock proteins [112,113]. Remarkably, neither the redox state of
the Trxs nor the active site cysteines or other amino acids
important for redox function are required for chaperone activity
[112,111]. Moreover, Trx from E. coli can stimulate the refolding
of MglB, a protein without cysteines [112]. Even though Trx and
YbbN/Trxsc promote the renaturation of citrate synthase, they
do not protect citrate synthase against thermal degradation. In-
terestingly, TrxR from E. coli protects citrate synthase as efficient
as DnaK from thermal degradation [112,113]. Unlike molecularchaperones, TrxR, Trx and YbbN/Trxsc do not preferentially bind
unfolded proteins [112,113].
Eukaryotic mitochondrial monothiol Grx5 was implied in
iron–sulfur cluster biosynthesis [74,75]. Depletion of Grx5 led
to increased iron levels and decreased enzymatic function of
iron–sulfur proteins such as aconitase and succinate dehydro-
genase [74]. In eukaryotes iron–sulfur cluster biosynthesis
takes place in mitochondria. The clusters are first assembled on
scaffold proteins and subsequently transferred to their target
proteins (reviewed in [114]). This transfer is dependent on a
functional HscA/HscB chaperone system [115]. The phenotype
of Grx5 deletion in yeast can be rescued by overexpression of
the HscA-type chaperone Ssq1 [74]. Biochemical data from
Mühlenhoff et al. [75], showing that deletion of Grx5 resulted in
accumulation of iron–sulfur clusters on the scaffold protein,
supports the model that Grx5 may act in concert with the HscA/
Ssq1 HscB/Jac1 chaperone couple in the transfer of the iron–
sulfur cofactor from the scaffold to the target protein.
Several proteomic approaches aiming at the identification of
new targets of the Trx and Grx systems indicate interactions
between these proteins and molecular chaperones. Human Trx1
was identified as interaction partner of 14-3-3… proteins during
interphase and mitosis in HeLa cells [116]. Using poplar Grx-
C4 as bait and several plant extracts as samples Rouhier et al.
identified a 14-3-3 protein (At5g6543), Hsp60, Hsp70 and
cyclophilin as interacting proteins [117]. Cyclophilin was also
found in investigations aiming at the identification of new targets
of A. thaliana cytosolic Trx-h3 and spinach plastidic Trx-m
[118,119]. Cyclophilin, a peptidyl-prolyl cis–trans isomerase
essential for protein folding [120,121] is activated via reduction
by spinach Trx-m [122]. Synergistically with α-crystallin, the Trx
system can recover inactivated GR in human aged clear and ca-
taract lenses [123]. The Trx system is known to interact with
peroxiredoxins (Prxs), some of which were characterized as cha-
perones. The yeast cytosolic Prxs 1 and 2 and the human Prx2
interact with unfolded substrates and do suppress thermal de-
gradation of citrate synthase [124,125]. Human Prx1 protects ma-
late dehydrogenase against heat-induced denaturation [126]. Like
other chaperones yeast Prx1 forms temperature-dependent multi-
mers, thus increasing chaperone activity and decreasing peroxidase
activity [124]. As for Trx, this chaperone activity was independent
of the conserved active site cysteines [124]. In contrast, H2O2
induced chaperone activity of yeast and human Prxs 2 requires the
active site cysteinyl side chains and the Trx system as cofactor
[124,125]. In concert with yeast Prx2, the Trx system protects
ribosomes against stress-induced aggregation [127].
Several chaperones have been characterized to be redox
regulated by reversible oxidation of thiol groups [128,129]. Trx
and Grx catalyze the reduction of protein disulfides in E. coli
Hsp33 [130], yeast Ssp2 [131], and humanHdj2 [132]. Proteomic
approaches identified the following chaperones as being regulated
by reversible glutathionylation: Hsp10, [133], Hsp60 [134,135],
Hsp70 [134–136,133], Hsp90 [134], Hsc70 [134,136], 14-3-3
proteins [134], and cyclophilin A [135,136,133]. Reversible glu-
tathionylation was also described as negative regulatory mecha-
nism for human Cox17 activity [137]. Grxs are highly specific for
protein–GSH mixed disulfides. Hence, all the above mentioned
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vivo. In fact, glutathionylated human Hsc70 was characterized as
substrate for Grx1, reduction of the mixed disulfide decreased
chaperone activity [138].
4. Concluding remarks
A wealth of results shows that Trxs and Grxs participate at
multiple stages in protein folding. New thioredoxins and glu-
taredoxins, such as the emerging group of monothiol Grxs, have
already been implied in protein maturation. Members of the
thioredoxin superfamily of proteins show a general preference
for protein–protein interactions, employing the Trx fold as uni-
versal interaction scaffold. The different systems are not in
thermodynamic equilibrium but kinetic factors and the distribu-
tion of the thioredoxin superfamily members in compartments
and associated NADPH dependent enzymes and GSH and
GSSG concentrations determine have to be taken in account. It
can be expected that future research will yield more functions of
thioredoxins and glutaredoxins and related proteins as faci-
litators and regulators of protein folding.
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